Bisoprolol and Hydrochlorothiazide
Thiazide Diuretic
NADAC/unit
$0.1951
No Shortage
Tier 1: 153.8%
8 Manufacturers
24 ANDAs
Bisoprolol and Hydrochlorothiazide reduces fluid retention and lowers blood pressure by increasing urine output.
Market Intelligence
2026-02-11 Class II Recall: Unichem Pharmaceuticals USA Inc.
2025-12-10 Class III Recall: Glenmark Pharmaceuticals Inc., USA
2023-11-08 Class III Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
AUROBINDO PHARMA LTDCADILA HEALTHCARE LTDEDENBRIDGE PHARMACEUTICALS LLCEPIC PHARMA LLCGLENMARK PHARMACEUTICALS LTDMYLAN PHARMACEUTICALS INCNOVITIUM PHARMA LLCTEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLCUNICHEM LABORATORIES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.